Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-27

FDA Approved: FLUVASTATIN SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's generic fluvastatin sodium as an original ANDA, enabling its use to treat hyperlipidemia and reduce cardiovascular risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvastatin sodium (Fluvastatin sodium)

Snippet

ORIG AP for FLUVASTATIN SODIUM (FLUVASTATIN SODIUM)